Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 2.2 Description of Securities
- 4.18 Financing Commitment Extension Letter to the Board of Directors of the Company from DR. Yacov Geva, Dated May 15, 2023
- 12.1 Certification
- 12.2 Certification
- 13.1 Certification
- 13.2 Certification
- 15.1 Consent of Ziv Haft, a Member Firm of Bdo
- Download Excel data file
- View Excel data file
GMVDF similar filings
Filing view
External links
Exhibit 13.2
CERTIFICATION PURSUANT TO
18 U.S.C. Section 1350
In connection with the filing of the Annual Report on Form 20-F for the period ended December 31, 2022 (the “Report”) by G Medical Innovations Holdings Ltd. (the “company”), the undersigned, as the Chief Financial Officer of the company, hereby certifies pursuant to 18 U.S.C. Section 1350, that, to my knowledge:
(1) the Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the company.
Date: May 16, 2023 | /s/ Igor Bluvstein |
Igor Bluvstein | |
Chief Financial Officer |